Research programme: serotonin 1A receptor inverse agonists - Recordati

Drug Profile

Research programme: serotonin 1A receptor inverse agonists - Recordati

Alternative Names: REC-27/0074; REC-27/0224

Latest Information Update: 28 Apr 2009

Price : $50

At a glance

  • Originator Recordati
  • Class
  • Mechanism of Action Serotonin 1A receptor inverse agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • On Fast track

    Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.


Highest Development Phases

  • No development reported Major depressive disorder

Most Recent Events

  • 28 Apr 2009 No development reported - Preclinical for Depression in Italy (unspecified route)
  • 12 Jun 2006 Preclinical trials in Depression in Italy (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top